Category: Inside BIO Industry Analysis
August is National Immunization Awareness Month
August is National Immunization Awareness Month (NIAM), which is a great opportunity to recognize the …
BIO Releases Largest Study Ever on Clinical Development Success Rates
On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in …
The Guardian: Global defence system to fight virus threats urgently needed
Fresh on the heels of the recent Ebola epidemic, the current Zika virus threat has …
Improving Oncology Clinical Trials
The 18th Annual BIO CEO & Investor Conference kicked off with a panel focused on oncology …
2015 FDA Approvals: Highest Levels in Over a Decade
2015 was a blockbuster year for FDA approvals of novel new medicines, many of them …
Interstitial Cystitis: Understanding What It Is, and the Interstitial Cystitis Association’s Role...
If you mention Interstitial Cystitis (IC) to most people, including physicians, the majority of people …
The Liquid Gold Rush For Biopsies
Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion …
Setting the Record Straight on Innovation and Drug Development
Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, …
See What’s New at the 2015 BIO Investor Forum
The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to …
Academics Weigh In on Journal Article: “GMOs, Herbicides, and Public Health”
An article published in the New England Journal of Medicine by biotech critics Philip Landrigan …